Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 653.1B | 590.5B | 626.5B | 660.3B |
Cost of revenue | 462.8B | 422.9B | 449.6B | 466.5B |
Gross profit | 190.3B | 167.6B | 176.9B | 193.8B |
Operating expense | ||||
Research & development | — | 7.5B | 8.3B | 7.4B |
Selling general and admin | 130.3B | 60.9B | 53.6B | 53.9B |
Other operating expenses | — | 2.7B | 2.8B | 3.0B |
Operating income | 190.3B | 35.2B | 54.5B | 71.7B |
Non operating interest income | ||||
Income | — | 1.9B | 2.1B | 1.0B |
Expense | — | 11.1B | 14.9B | 8.5B |
Other income expense | — | — | — | — |
Pretax income | 32.4B | 24.8B | 35.5B | 59.3B |
Tax provision | 9.2B | -19.7B | 11.8B | 14.1B |
Net income | 23.2B | 44.4B | 23.6B | 45.2B |
Basic EPS | 561.2 | — | 651 | 1.5K |
Diluted EPS | 561.2 | — | 651 | 1.5K |
Basic average shares | — | — | 23.6M | 23.6M |
Diluted average shares | — | — | 23.6M | 23.6M |
EBITDA | 190.3B | 67.2B | 86.6B | 100.7B |
Net income from continuing op. | — | 44.4B | 23.6B | 45.2B |
Minority interests | -9.9B | -10.9B | -8.3B | -10.3B |
Preferred stock dividends | — | — | — | — |